Aspirin-induced increases in soluble IL-1 receptor type II concentrations in vitro and in vivo

Journal of Leukocyte Biology

Volumn 65, Issue 6, 1999, Pages 863-866

  Daun, Jane M ^a   Ball, Richard W ^a   Burger, Heather R ^a   Cannon, Joseph G ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Endotoxin; Human mononuclear cells; IL 1

Indexed keywords

ACETYLSALICYLIC ACID; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MALE; MONONUCLEAR CELL; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0033003557     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1002/jlb.65.6.863     Document Type: Article

References (27)

1. Arend, W. P. (1993) Interleukin-1 receptor antagonist. Adv. Immunol. 54, 167-227.
2. Colotta, F., Dowers, S. K., Sims, J. E., Mantovani, A. (1994) The type II 'decoy' receptor: a novel regulatory pathway for interleukin-1. Immunol. Today 15, 562-566.
3. Colotta, F., Orlando, S., Faldon, E. J., Sozzani, S., Matteucci, C., Montonvani, A. (1995) Chemoattractants induce the rapid release of interleukin-1 type II decoy receptor in human polymorphonuclear cells. J. Exp. Med. 181, 2181-2186.
4. Colotta, F., Saccani, S., Giri, J. G., Dowers, S., Sims, J., Introna, M., Mantovani, A. (1996) Regulated expression and release of the IL-1 decoy receptor in human mononuclear phagocytes. J. Immunol. 156, 2534-2541.
5. Orlando, S., Matteucci, C., Faldon, E. J., Buurman, W. A., Bardella, M. T., Collata, F., Introna, M., Mantovani, A. (1997) TNF-α, unlike other pro-and anti-inflammatory cytokines, induces the release of the IL-1 type II decoy receptor in human myelomonocytic cells. J. Immunol. 158, 3861-3868.
6. Symons, J. A., Young, P. R., Duff, G. W. (1995) Soluble type II IL-1 receptor binds and blocks processing of IL-1β precursor and loses affinity for IL-1 receptor antagonist. Proc. Natl. Acad. Sci. USA 92, 1714-1718.
7. Johnston, S. A., Fox, S. M. (1997) Mechanisms of action of anti-inflammatory medications used for the treatment of osteoarthritis. J. Am. Vet. Med. Assoc. 210, 1486-1492.
8. Fuster, V., Dyken, M. L., Vokonas, P. S., Hennekens, C. (1993) Aspirin as a therapeutic agent in cardiovascular disease. Circulation 87, 659-675.
9. Ngai, P. K. M., Ackermann, F., Wendt, H., Savoca, R., Bosshard, H. R. (1993) Protein A antibody-capture ELISA: an ELISA format to avoid denaturation of surface absorbed antigens. J. Immunol. Meth. 158, 267-276.
10. van der Poll, T., Malefyt, R. W., Coyle, S. M., Lowry, S. F. (1997) Antiinflammatory cytokine responses during clinical sepsis and experimental endotoxemia: Sequential measurements of plasma soluble interleukin (IL-1) receptor type II, IL-10, and IL-13. J. Infect. Dis. 175, 118-122.
11. Giri, J. G., Wells, J., Dower, S. K., McCall, C.E., Guzman, R.N., Slack, J., Bird, T. A., Shanebeck, K., Grabstein, K. H., Sims, J. E., Alderman, M. R. (1994) Elevated levels of shed type II IL-1 receptor in sepsis. J. Immunol. 153, 5802-5809.
12. Pruitt, J. H., Buress Welcome, M., Edwards, P. D., Harward, T. R. S., Seeger, J. W., Martin, T. D., Smith, C., Kenney, J. A., Wesdorp, R. I. C., Meijer, S., Cuesta, M. A., Abouhanze, A., Copeland, E. M., Giri, J., Sims, J. E., Moldawer, L. L., Olderburg, H. S. A. (1996) Increased soluble interleukin-1 type II receptor concentrations in post-operative patients and in patients with sepsis syndrome. Blood 87, 3282-3288.
13. Arend, W. P., Malyak, M., Smith, M. F., Whisenand, T. D., Slack, J. L., Sims, J. E., Giri, J. G., Dower, S. K. (1994) Binding of IL-1α, IL-1β and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble receptors in synovial fluids. J. Immunol. 153, 4766-4774.
14. Rauschmayr, T., Groves, R. W., Kupper, T. S. (1997) Keratinocyte expression of the type 2 interleukin 1 receptor mediates local and specific inhibition of interleukin-1 mediated inflammation. Proc. Natl. Acad. Sci. USA 94, 5814-5819.
15. Brown, E. A., Dare, H. A., Marsh, C. B., Wewers, M. D. (1996) The combination of endotoxin and dexamethasone induces type II interleukin 1 receptor (IL-1rII) in monocytes: A comparison to interleukin 1β and interleukin 1 receptor antagonist (IL-1ra). Cytokine 8, 828-836.
16. Saccani, S., Polentarutti, N., Penton-Rol, G., Sims, J., Montovani, A. (1998) Divergent effects of LPS on expression of IL-1 receptor family members in mononuclear phagocytes in vitro and in vivo. Cytokine 10, 773-780.
17. Endres, S., Cannon, J. G., Ghorbani, R., Dempsey, R. A., Sisson, S. D., Lonnemann, G., Van der Meer, J. W. M., Wolff, S. M., Dinarello, C. A. (1989) In vitro production of IL1β, IL1α, TNF, and IL-2 in healthy subjects: distribution, effects of cylcooxygenase inhibition and evidence of independent gene regulation. Eur. J. Immunol. 19, 2327-2333.
18. Pairet, M., Engelhardt, G. (1996) Distinct isoforms (COX-1 and COX-2) of cylcooxygenase: possible physiological and therapeutic implications. Fund. Clin. Pharmacol. 10, 1-17.
19. Miralpeix, M., Camacho, M., Lopez-Belmonte, J., Canalias, F., Beleta, J., Palacios, J. M., Vila, L. (1997) Selective induction of cyclooxygenase-2 activity in the permanent human endothelial cell line HUVEC: biochemical and pharmacological charaterization. Br. J. Pharmacol. 121, 171-180.
20. Famaey, J. P. (1997) In vitro and in vivo pharmacological evidence of selective cyclooxygenase-2 inhibition by nimesulide: An overview. Inflamm. Res. 46, 437-446.
21. Kunkel, S. L., Chensue, S. C., Phan, S. H. (1986) Prostaglandins as endogenous mediators of interleukin 1 production. J. Immunol. 136, 186-192.
22. Kopp, E., Ghosh, S. (1994) Inhibition of NF-κB by sodium salicylate and aspirin. Science 265, 956-959.
23. Frantz, B., O'Neill, E. A. (1995) The effect of sodium salicylate and aspirin on NF-κB. Science 270, 2017-2018.
24. Dong, Z., Huang, C., Brown, R. E., Ma, W. (1997) Inhibition of activator protein 1 activity and neoplastic transformation by aspirin. J. Biol. Chem. 272, 9962-9970.
25. Galea, J., Armstrong, J., Gadsdon, P., Holden, H., Francis, S. E., Holt, C. M. (1996) Interleukin-1β in coronary arteries of patients with ischemic heart disease. Arterioscler. Thromb. Vasc. Biol. 16, 1000-1006.
26. Shimokawa, H., Ito, A., Fukumoto, Y., Kadokami, T., Nakaike, R., Sakata, M., Takayanagi, T. (1996) Chronic treatment with interleukin-1β induces coronary intimal lesions and vasospastic responses in pigs in vivo. J. Clin. Invest. 97, 769-776.
27. Elhage, R., Maret, A., Pieraggi, T., Thiers, J. C., Arnal, J. F., Bayard, F. (1998) Differential effects of interleukin-1 receptor antagonist and tumor necrosis factor binding protein on fatty-streak formation in apolipoprotein E-deficient mice. Circulation 97, 242-244.